SCHEMBL17425513

SCHEMBL17425513

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4cccc(-c5cccc(-c6cccc7c6oc6c(-c8ccccc8)cccc67)c5)c4)n3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.43
PRKDC P78527 10/20 0.43
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
TP53 P04637 2/20 0.40
TSHR P16473 2/20 0.40
NFKB1 P19838 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPK1 P28482 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PIK3CD O00329 3/20 0.40
PIK3CA P42336 3/20 0.40
PIK3CB P42338 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17425496 1.00 ALOX5 (0.43) ALOX5PRKDCALDH1A1KDM4ESMN1; SMN2
SCHEMBL17425529 1.00 ALOX5 (0.43) ALOX5PRKDCALDH1A1KDM4ESMN1; SMN2
SCHEMBL17425561 1.00 ALOX5 (0.43) ALOX5PRKDCALDH1A1KDM4ESMN1; SMN2
SCHEMBL17425703 0.98 PRKDC (0.41) ALOX5PRKDCALDH1A1KDM4ESMN1; SMN2
SCHEMBL17425598 0.98 PRKDC (0.41) ALOX5PRKDCALDH1A1KDM4ESMN1; SMN2
SCHEMBL17425660 0.98 PRKDC (0.41) ALOX5PRKDCALDH1A1KDM4ESMN1; SMN2
SCHEMBL17425695 0.98 PRKDC (0.41) ALOX5PRKDCALDH1A1KDM4ESMN1; SMN2
SCHEMBL17425674 0.98 PRKDC (0.41) ALOX5PRKDCALDH1A1KDM4ESMN1; SMN2
SCHEMBL17425521 0.98 PRKDC (0.41) ALOX5PRKDCALDH1A1KDM4ESMN1; SMN2
SCHEMBL17425474 0.98 ALOX5 (0.44) ALOX5PRKDCALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170054087-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-02-23 US disclosed
US-20160093808-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-03-31 US disclosed
US-20160028021-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-28 US disclosed
EP-2966706-A2 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2016-01-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160028021-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OR10J3 ALOX5 336/4885PRKDC 4297/4885ALDH1A1 1130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.